Viewing Study NCT06337695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2026-02-03 @ 3:24 AM
Study NCT ID: NCT06337695
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-02
First Post: 2024-03-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer
Sponsor: University of Calgary
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Cancer Metastatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune Checkpoint Inhibitors View